KEVIN D. MCCORMICK,CHRISTOPHER W. BOYCE,NENG-YANG SHIH,ROBERT G. ASLANIAN,SALEM FEVRIER,PIETRO MANGIARACINA,MANUEL DE LERA RUIZ,JUNYING ZHENG,CHIA-YU HUANG,BO LIANG,RONG-QIANG LIU,RUIYAN LIU,LISA GUIS
申请号：
BRPI0807911
公开号：
BRPI0807911A2
申请日:
2008.02.11
申请国别(地区):
BR
年份:
2014
代理人:
摘要：
In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine compounds useful as &alpha；2C adrenergic receptor agonists, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the &alpha；2C adrenergic receptor agonists using such compounds or pharmaceutical compositions.
